Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer - PubMed (original) (raw)
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer
B Passlick et al. J Clin Oncol. 1994 Sep.
Abstract
Purpose: This prospective study was designed to evaluate the prognostic relevance and biologic characteristics of a minimal lymphatic tumor load in non-small-cell lung cancer (NSCLC).
Methods: Frozen-tissue sections from 391 regional lymph nodes of 72 patients with completely resected NSCLCs, who were staged as free of metastases (pT1-3, pN0,M0,R0) by clinical tumor staging procedures and histopathologic examinations, were studied. For tumor-cell detection, we applied the alkaline phosphatase-antialkaline phosphatase (APAAP) immunostaining technique with monoclonal antibody Ber-Ep4 against two glycoproteins of 34 and 49 kd present of the surface and cytoplasm of epithelial cells.
Results: Individual Ber-Ep4-positive cells were detected in 11 of 72 (15.2%) cancer patients, while positive staining was consistently absent in all sections from control nodes of 24 noncarcinoma patients. No correlation between a positive lymph node finding and either the size or differentiation grade of the primary tumor or the presence of micrometastatic tumor cells in bone marrow assessed by immunocytochemistry with antikeratin monoclonal antibody CK2 was observed. Following a median observation time of 26.0 months (range, 15 to 39), patients with lymph node micrometastases showed a significantly shorter disease-free survival duration than node-negative patients (log-rank test, P = .005). The independence of this prognostic significance was demonstrated by a multivariate analysis (Cox regression model, P = .005).
Conclusion: Our results provide evidence that the presence of single lung carcinoma cells in lymph nodes is an independent indicator of the disseminatory capacity of an individual primary tumor. Immunohistochemical assessment of micrometastases in lymph nodes is recommended for current tumor staging in NSCLC, as it might lead to better stratification of patients for adjuvant therapy.
Similar articles
- Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer.
Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Kubuschok B, et al. J Clin Oncol. 1999 Jan;17(1):19-24. doi: 10.1200/JCO.1999.17.1.19. J Clin Oncol. 1999. PMID: 10458213 - Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis.
Izbicki JR, Passlick B, Hosch SB, Kubuschock B, Schneider C, Busch C, Knoefel WT, Thetter O, Pantel K. Izbicki JR, et al. J Thorac Cardiovasc Surg. 1996 Sep;112(3):623-30. doi: 10.1016/S0022-5223(96)70044-2. J Thorac Cardiovasc Surg. 1996. PMID: 8800148 - Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Passlick B, et al. Ann Thorac Surg. 1996 Jan;61(1):177-82; discussion 183. doi: 10.1016/0003-4975(95)01012-2. Ann Thorac Surg. 1996. PMID: 8561549 - Micrometastases in non-small cell lung cancer (NSCLC).
Passlick B. Passlick B. Lung Cancer. 2001 Dec;34 Suppl 3:S25-9. doi: 10.1016/s0169-5002(01)00375-0. Lung Cancer. 2001. PMID: 11740989 Review. - Detection and relevance of immunohistochemically identifiable tumor cells in lymph nodes.
Passlick B, Pantel K. Passlick B, et al. Recent Results Cancer Res. 2000;157:29-37. doi: 10.1007/978-3-642-57151-0_4. Recent Results Cancer Res. 2000. PMID: 10857160 Review.
Cited by
- Lymph Node and Bone Marrow Micrometastases Define the Prognosis of Patients with pN0 Esophageal Cancer.
Karstens KF, Ghadban T, Effenberger K, Sauter G, Pantel K, Izbicki JR, Vashist Y, König A, Reeh M. Karstens KF, et al. Cancers (Basel). 2020 Mar 4;12(3):588. doi: 10.3390/cancers12030588. Cancers (Basel). 2020. PMID: 32143307 Free PMC article. - Novel Techniques to Study the Bone-Tumor Microenvironment.
Shupp AB, Kolb AD, Bussard KM. Shupp AB, et al. Adv Exp Med Biol. 2020;1225:1-18. doi: 10.1007/978-3-030-35727-6_1. Adv Exp Med Biol. 2020. PMID: 32030644 Review. - Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspiration.
Belanger AR, Hollyfield J, Yacovone G, Ceppe AS, Akulian JA, Burks AC, Rivera MP, Dodd LG, Long JM, Haithcock BE, Pecot CV. Belanger AR, et al. J Thorac Dis. 2019 Aug;11(8):3650-3658. doi: 10.21037/jtd.2019.05.36. J Thorac Dis. 2019. PMID: 31559073 Free PMC article. - EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression.
Liu L, Yang Y, Liu S, Tao T, Cai J, Wu J, Guan H, Zhu X, He Z, Li J, Song E, Zeng M, Li M. Liu L, et al. Oncogene. 2019 Jan;38(5):747-764. doi: 10.1038/s41388-018-0473-z. Epub 2018 Sep 3. Oncogene. 2019. PMID: 30177836 Free PMC article. - NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma.
Sun Y, Chen Y, Li S, Lei Y, Xu D, Jiang N, Zhang Y, Cao J, Ke Z. Sun Y, et al. Int J Nanomedicine. 2017 Aug 31;12:6399-6412. doi: 10.2147/IJN.S144033. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28919743 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical